United Therapeutics reported $102M in Stock for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Amarin AMRN:US USD 227.61M 1.83M
Ardelyx ARDX:US USD 3.28M 2.03M
Biocryst Pharmaceuticals BCRX:US USD 27.53M 514K
Biogen BIIB:US USD 1.34B 30.6M
Biomarin Pharmaceutical BMRN:US USD 894.08M 54.62M
Emergent Biosolutions EBS:US USD 351.8M 194.5M
Esperion Therapeutics ESPR:US USD 35.2M 5.66M
Gilead Sciences GILD:US USD 2.82B 218M
GlaxoSmithKline GSK:LN GBP 5.15B 487M
Halozyme Therapeutics HALO:US USD 100.12M 3.15M
Insmed INSM:US USD 69.92M 3.65M
Intercept Pharmaceuticals ICPT:US USD 6.46M 188K
Intra Cellular Therapies ITCI:US USD 23.92M 323K
Moderna Inc MRNA:US USD 949M 1.13B
Ptc Therapeutics PTCT:US USD 21.81M 7M
Regeneron Pharmaceuticals REGN:US USD 2.4B 10.3M
Sarepta Therapeutics SRPT:US USD 203.97M 17.22M
Seattle Genetics SGEN:US USD 427.21M 62.24M
Teva Pharmaceutical TEVA:IT USD 3.83B 26M
United Therapeutics UTHR:US USD 102M 11M
Vertex Pharmaceuticals VRTX:US USD 460.6M 72.4M